KALA Archived Articles
KALA BIO, Inc. (NASDAQ:KALA): A Steadfast Player in the Rare Eye Disease Landscape
Published on November 30, 2024
KALA Bio, Inc. (KALA): A Promising Biopharmaceutical Company Focused on Rare Eye Diseases
Published on September 24, 2024